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ABSTRACT 
  
 Blood glucose levels are regulated by the interactions between insulin and glucagon.  
Pancreatic alpha cells release glucagon in response to a drop in blood sugar.  Pancreatic alpha cells 
appear to be regulated through multiple signaling pathways.  One potential method of regulation 
occurs from α-MSH or epinephrine stimulated production of the intracellular messenger cyclic 
AMP.  Exocytosis of dense core vesicles containing glucagon ultimately requires an increase in 
cytosolic Ca2+.  This study focused on the link between cyclic AMP and calcium in pancreatic alpha 
cells which allows alpha cell regulation.  Interactions between calcium and cyclic AMP in pancreatic 
alpha cells consists of PKA-dependant and PKA-independent pathways.  The results indicate cyclic 
AMP  pathways control L-type voltage-gated calcium channels and also increase cytoplasmic 
calcium from intracellular stores.  Store release appears to be through IP3 mediated pathways and not 
through the ryanodine-sensitive receptor.  
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Introduction 
 Regulation of blood glucose levels occurs from the secretory products from the islets 
of Langerhans.  When blood glucose levels rise β-cells release insulin to lower blood 
sugar and when blood sugar drops too low, α-cells release glucagon in order to increase 
plasma glucose levels.  This regulation is essential and when problems occur within this 
endocrine system, control of plasma glucose levels is jeopardized.  Understanding the 
mechanisms by which glucose is regulated provides insight about how to treat disruptions 
in glucose homeostasis.   
Composition and Structure of the Islets of Langerhans 
The endocrine pancreas is composed of the islets of Langerhans within the pancreas 
(Quesada et al, 2008).  A healthy human pancreas contains approximately one million 
islets, which constitutes one to two percent of the total mass of the pancreas (Quesada et 
al, 2008).  The size of individual islets varies from 100 to 500 microns and contains 
approximately 1000 to 3000 cells (Quesada et al, 2008).  
 Within the islets of Langerhans five different cell types exist.  In the human pancreas 
insulin secreting β-cells compose 48 to 59 percent of the islets (Quesada et al, 2008), 
glucagon secreting α-cells compose 33 to 46 percent (Quesada et al, 2008), somatostatin 
secreting δ-cells less than 10 percent (Cabrera et al, 2006), pancreatic polypeptide-
secreting cells 5 percent (Quesada et al, 2008), and ghrelin -producing cells have also 
been observed (Quesada et al, 2008, Gromada et al, 2007,Cabrera et al, 2006).  However, 
the mouse and rat pancreas contain a higher percent of β-cells, which account for 60 to 
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80 percent, while α-cells account for 15 to 20 percent (Quesada et al, 2008; Rorsman et 
al, 2008).  In the majority of species, pancreatic polypeptide-secreting cells and 
somatostatin cells are minority cell types, while β-cells are the most abundant (Cabrera et 
al, 2006).   
 The actual structure of the islets of Langerhans differs across species. Human 
pancreases have a random distribution pattern of cell types, where β-cells come into 
contact with non β-cells (Quesada et al, 2008; Gromada et al, 2007).  A difference exists 
between islet organization in rodents and primates (Cabrera et al, 2006).  Cross-sectional 
studies show that mouse and rat islets are more organized than primate islets, where in 
rodent islets the β-cells are located in the core of the islet and the α-cells, δ-cells, and 
pancreatic polypeptide-secreting cells are dispersed around the mantle of the islet 
(Quesada et al, 2008; Gromada et al, 2007; Cabrera et al, 2006).  A random distribution 
pattern in primates suggests possible paracrine interactions between different cell types 
(Gromada et al, 2007).  The organization of the islets facilitates paracrine regulation of 
the α-cells by the β-cells (Rorsman et al, 2008). 
Physiological Glucose Regulation 
 Blood glucose levels are regulated by the cellular secretions of insulin and 
glucagon from the endocrine component of the pancreas, the islets of Langerhans 
(Quesada et al, 2008; Quesada et al, 2006).  Fasting plasma glucose levels range from 
four to seven millimolar, and two hours after food intake, glucose levels should range 
from eight to ten millimolar.  As blood sugar increases, β-cells respond by secreting 
insulin, which acts on muscle, liver and adipose tissue causing the tissues to incorporate 
glucose in the form of glycogen and fat (Quesada et al, 2008; Quesada et al, 2006).  α-
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Cells release glucagon in response to a drop in blood glucose, which initiates 
glycogenolysis and gluconeogenesis leading to an increase in blood glucose (Quesada et 
al, 2008; Rorsman et al, 2008; Quesada et al, 2006).  Abnormal function of cells in the 
islets leads to the development of diabetes from the loss of control of blood glucose 
levels (Quesada et al, 2008).  Having higher levels of glucagon compared to insulin 
causes elevated levels of glucose output, leading to sustained hyperglycemia in diabetic 
patients (Quesada et al, 2008).  Little is understood about α-cells physiology in 
comparison to β-cells physiology because the scarcity of the cells and the lack of 
functional identification patterns (Quesada et al, 2008; Ravier et al, 2005).  The 
molecular regulation of α-cells remains scarcely understood (Ravier et al, 2005). 
 Physiological regulation of glucagon secretion from α-cells involves input from 
paracrine, neuronal and intrinsic mechanisms (Rorsman et al, 2005, 2008).  When nerves 
have been severed, glucagon secretion can still be regulated, which suggests that neuronal 
connections are not the only thing regulating α-cells (Rorsman et al, 2005, 2008).  
Pancreatic α-cells contain channels that generate action potentials, or sense voltage 
changes when glucose levels are low or absent (Quesada et al, 2008).  Voltage-gated 
sodium and calcium channels play a major role in creating these action potentials 
(Quesada et al, 2008).  Electrical activity controls Ca2+ influx and the Ca2+ signals that 
control glucagon secretion (Quesada et al, 2008).  Elevated levels of glucose seem to 
inhibit the Ca2+ signals and glucagon secretion (Quesada et al, 2008).  Glucagon should 
not be secreted when plasma glucose levels are high, making this an important aspect of 
regulation in α-cells.  However, direct glucose effects would stimulate secretion in α-
cells through the ATP-dependant K+ (KATP) channel (Quesada et al, 2008).  In humans 
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and rodents paracrine signals from other islet cells have inhibitory action on glucagon 
secretion. In addition, the presence of elevated glucose might directly suppress glucagon 
secretion and lastly the hypothalamus might have control of secretion (MacDonald et al).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Blood glucose regulation.  Plasma glucose levels are primarily regulated 
through the secretions from β-cells and α-cells.  Signals that cause α-cells to secrete 
glucagon still remain unknown. 
 
ATP-Sensitive Potassium Channels 
 ATP-sensitive K+ channels are inhibited by an increase in intracellular ATP 
concentrations (Ashcoroft et al, 2000).  The KATP channels have a significant impact on 
membrane potential and action potential (Quesada et al, 2008).  The mechanism in α-
cells by which the KATP channel works is still in question.  α-Cells possess the same type 
of KATP channel as those that effect membrane potential in β-cells (Rorsman et al, 2008).  
After Food… 
High Blood Glucose 
β Cell Insulin Store Glucose 
Fasting… 
Low Blood Glucose 
α Cell 
Glucagon Release Stored 
Glucose 
? 
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It is unclear how KATP depolarization stimulates β-cells to release insulin, however it is 
not known how KATP inhibits α-cells to release glucagon (MacDonald et al, 2007).   
 β-Cells have comparable densities of KATP channels as α-cells (Gromada et al, 
2007), which allows for some comparison about how they function in the α-cells.  In β-
cells, inhibition of the KATP channels leads to depolarization, which ultimately leads to 
exocytosis of insulin (Ashcoroft et al, 2000).  This channel is critical for glucose induced 
insulin release (Béguin, 1999).  At rest β-cells have a negative membrane potential, 
around -70 mV (Gromada et al, 2007).  In low levels of glucose KATP channels 
spontaneously open in β-cells, leading positively charged potassium to leave the cell, 
which creates a less negative membrane potential (Rorsman, 2003).  Glucose enters β-
cells through the glut2 transporter, which leads to increased ATP production (Rorsman, 
2003).  As extracellular glucose levels rise, more glucose enters the cell leading to an 
increase in production of ATP.  This produces a concentration-dependent inhibition of 
the KATP channel due to the changing concentrations of ATP and ADP (Gromada et al, 
2007).  Rising ATP inhibits the function of the KATP channel causing the channel to close 
(Gromada et al, 2007; Ashcoroft et al, 2000).  Closing of the KATP channel causes the 
membrane to depolarize (Gromada et al, 2007).  The change in membrane potential 
activates the voltage-gated calcium channels, which causes the calcium channels to open 
and allow calcium to enter the cell.  Rising calcium levels generates calcium dependent 
exocytosis of dense core vesicles containing insulin (Gromada et al, 2007; Ravier et al, 
2005).   
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 Similarly in isolated rat α-cells high concentrations of glucose cause the KATP 
channel to close and this ultimately leads to calcium influx and secretion (Quesada et al, 
2008).  It is paradoxical for α-cells release glucagon to increase glucose levels, when 
glucose levels are already high.  However, in vivo α-cells do not respond to high glucose 
levels (Quesada et al, 2008).  Bringing up the questions of why α-cells have the same 
KATP channel as β-cells, and how are they regulated in α-cells, if α-cells are not supposed 
to secrete glucagon in high levels of glucose (Rorsman et al, 2008; MacDonald et al, 
2007).  
 One study showed that without the presence of β-cells, glucose caused a rise in 
free cellular ATP concentrations in clonal mouse α-TC1-9 cells (Ravier et al, 2005) 
causing the KATP channel to be blocked.  Calcium oscillations were also inhibited by an 
increase in glucose concentrations and insulin in α-TC1-9 (Ravier et al, 2005).   In α-
cells lower levels of ATP are needed in order to have maximal inhibition of KATP 
conductance than that required in β-cells (Quesada et al, 2008).   Unlike β-cells, 
physiologically α-cells should be activated in low plasma glucose concentrations, since 
glucagon will raise plasma glucose levels.  Sensitivity to KATP channels varies by 
different tissues (Ashcoroft et al, 2000), which might partially explain this different 
regulation in different cell types.  Glucagon release most likely happens at relatively low 
level of plasma glucose because of the intermediate activity of the KATP channel 
(Quesada et al, 2008).  Similar models of KATP function have been shown for human α-
cells (Quesada et al, 2008).   
 Several different models exist about glucagon secretion and α-cell depolarization.  
One theory suggests that glucose is hyperpolarizing cells as opposed to depolarizing the 
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cells (Quesada et al, 2008).  Another theory suggests glucose is inhibiting glucagon 
secretion by suppressing Ca2+ store-operated current independent of the KATP channel 
(Quesada et al, 2008).  α-Cells also differ from β-cells in that α-cells contain a large Na2+ 
current, which is essential for glucagon release (MacDonald et al, 2007). Finally, it seems 
evident that there are signals coming from somewhere else that are causing inhibition of 
secretion of α-cells.  α-Cells appear to be highly sensitive to secretory products from β-
cells supporting the idea that paracrine effects control α-cells secretion of glucagon 
(Gromada et al, 2007).  This paracrine inhibition is regulated by insulin/Zn2+, GABA 
from β-cells and somatostatin from δ-cells.   
Calcium Channels and Function 
 Calcium increase in β-cells is linked to three types of channels (Chen et al, 2009).  
The primary increase is due to influx through voltage-gated Ca2+ channels on the plasma 
membrane. Ca2+ increase can be augmented by ER-store release through ryanodine 
receptors and inosital 1,4,5-triphosphate receptors (IP3) (Chen et al, 2009).  In α-cells 
intracellular Ca2+ oscillations are interconnected to the electrical activity of the α-cell and 
reflect glucagon release by glucose (MacDonald et al, 2007).   
 Voltage-dependent calcium channels present in all excitable cells regulate 
calcium influx during membrane depolarization (Catterall et al, 2005).  These channels 
are transmembrane ion channels, composed of four or five distinct subunits (2000, 
Catterall et al, 2005).  The α1 subunit is the largest subunit, which incorporates the 
voltage sensor, conduction pore, gating apparatus and the site of regulation to which 
second messengers, drugs or toxins bind (2000; Catterall et al, 2005). Auxiliary subunits 
modulate the properties of the channel; however, multiple forms of the α1 subunit create 
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pharmacological and electrophysiological diversity in these complexes (Catterall et al, 
2005).  Four different subtypes of voltage-gated calcium channels have been reported in 
α-cells (Quesada et al, 2008).  It was reported that rat α-cells contain L- and N-type 
calcium channels, while mouse α-cells contain L-, N-, T- and R-type Ca2+ channels 
(Quesada et al, 2008).  All of these channels are functionally different. 
 L-type Ca2+ channels require strong depolarization for activation and are long-
lasting (2000; Catterall et al, 2005).  Typically L-type channels open during action 
potentials when the membrane exceeds -40 to -30 mV, however some activate at lower 
voltages, but these subtypes are predominately found in neurons and cardiac pacemaker 
cells (Quesada et al, 2008).  Under certain conditions, most of the Ca2+ currents in α-cells 
are thought to go through L-type Ca2+ channels (Quesada et al, 2008).  In the presence of 
cyclic adenosine monophosphate (cAMP) L-type channels become major conductors of 
the Ca2+ current in α-cells (Quesada et al, 2008).   
 N-type Ca2+ channels also require strong depolarization for activation and open 
during action potentials when the membrane potential exceeds -40 to -30 mV (Catterall et 
al, 2005, Quesada et al, 2008).  These channels are sensitive to voltage-dependent 
inactivation and at low levels of glucose; Ca2+ influx through the N-type channel 
mediates exocytosis (Quesada et al, 2008).  Mice lacking N-type Ca2+ channels show a 
decreased level of plasma glucagon, suggesting that these channels play a role in glucose 
regulation (Gromada et al, 2007).   
 T-type Ca2+ channels are activated by weak depolarizations and are transient 
(Catterall et al, 2005).  The channels are activated around -65 mV near threshold for 
action potential generation and may play a role in action potential initiation (Gromada et 
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al, 2007).  Toxins and organic antagonists used to define N- and P/Q- type currents do not 
have an effect on T-type Ca2+ currents (Catterall et al, 2005).  These work as pacemakers 
in initiation of action potentials and control repetitive firing (Quesada et al, 2008, 
Catterall et al, 2005).      
 The final type of Ca2+ channel that has been reported in α-cells are the R-type 
Ca2+ channels (Quesada et al, 2008; Gromada et al, 2007).  These also require strong 
depolarizations for activation (Catterall et al, 2005).    
Pro-opiomelanocortin and Epinephrine 
 Pro-opiomelanocortin (POMC) is expressed in a variety of tissues including the 
pituitary gland, skin, immune system and brain (Pritchard et al, 2002).  Sequenced 
mammalian POMC genes consists of three exons interspersed by introns (Millington, 
2007).  Post-translational processing by propeptide convertases, PC1 and PC2, leads to 
eight biologically active peptides (Millington).  The products include: adrenocorticotropic 
hormone (ACTH), β-lipotropin (LPH), corticotrpin-like intermediate peptide (CLIP), γ-
LPH, α-melanocyte stimulating hormone (MSH), β-endorphin, γ-MSH and β-MSH 
(Millington, 2007, Pritchard et al, 2002).  These peptides have important roles in skin, 
stress response, immune system, sexual behaviors and feeding behaviors (Millington, 
2007).  The POMC peptide products show biological effects through melanocortin 
recpectors (Pritchard et al, 2002).  
 Pro-opiomelanocortin (POMC) knockout mice lack important molecules in the 
regulation of glucose homeostasis (Hochgeschwender et al, 2003).  Glucose tolerance 
tests POMC-null mice reacted similarly to the control wild-type mice.  However, when 
POMC-null mice were challenged to insulin tolerance tests, glucose levels continued to 
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drop and eventually leading to death caused by hypoglycemic shock (Hochgeschwender 
et al, 2003).  When injected with α-MSH analog POMC-null mice were able to recover 
from the insulin tolerance test (Hochgeschwender et al, 2003).  This test indicates that 
MSH plays an important role in α-cell signaling and glucagon secretion.   
 Five different melanocortin (MC) receptors have been described, (MC1R-MC5R) 
(Cone, 2006).  All five receptors are known to be G protein-coupled receptors  (Rana, 
2003) and interact with Gαs proteins, leading to stimulation of adenylate cyclase and an 
increase in cAMP (Cone, 2006; Pritchard et al, 2002). cAMP is the main intracellular 
signal generated by melanocortin receptors (Cone, 2006).   
 Glucagon secretion in α-cells can also be stimulated by epinephrine.  Epinephrine 
binds to β adrenergic receptors, which leads to activation of adenylate cyclase.  Similarly 
to MSH, the adrenergic pathway may play an important role in α-cell regulation via 
stimulated production of cAMP.   
Cyclic Adenosine Monophosphate  
 Stimulation of heterotrimeric G-protein-coupled receptors can activate adenylate 
cyclase leading to an increase in cAMP (Bos et al, 2006; Ganong, 2005; Richards, 2001). 
Phosphodiesterase metabolizes cAMP (Ganong, 2005).  Cyclic AMP has several targets, 
which lead to different reactions in cells (Walsh et al, 1994).  This second messenger has 
many different physiological roles, all of which were initially attributed to cAMP binding 
to protein kinase A (PKA) leading to its activation (Kang et al, 2006; Bos et al, 2006).   
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Two pathways exist for cAMP, PKA-dependent and PKA-independent pathways 
(Gromada et al, 2007).  Specific targets of cAMP include: cAMP binding to PKA, 
cAMP-regulated ion channels and Epac (Exchange protein directly activated by cAMP) 
(Bos et al, 2006).   
 Three factors play a role in the ability for cAMP to bind to proteins in a cell 
(Walsh et al, 1994).  Proteins are often anchored near kinases, where they are more likely 
to be phosphorylated than interact with cAMP (Walsh et al, 1994).  Protein structures 
also play a role in the interaction between the protein and cAMP.  Tertiary structures of 
proteins and area surrounding the serine will influence the ability for the protein to be 
phosphorylated and will affect its ability to interact with cAMP (Walsh et al, 1994).  
Lastly, if proteins have allosteric interactions or covalent modifications this will influence 
the ability to bind to cAMP (Walsh et al, 1994).   
Protein Kinase A 
 cAMP activates Camp-dependent protein kinase (protein kinase A, PKA), which 
has several functions (Ganong, 2005).  PKA is composed of two catalytic subunits and 
two regulatory subunits (Ponsioen et al, 2004).  In order to activate PKA four molecules 
of cAMP are required, each regulatory subunit will bind two molecules of cAMP.  Upon 
cAMP binding the regulatory subunits dissociate from the catalytic subunits and the 
catalytic subunits become active (Ponsioen et al, 2004). Once active PKA catalyzes the 
phosphorylation of proteins that cause conformational changes that lead to a change in 
function (Ganong, 2005).  The proteins that become phosphorylated largely depend on 
subcellular localization (Walsh et al, 1994).  PKA has been shown to activate pathways, 
such as the mitogen-activated protein kinases in cell specific manners, cAMP regulatory 
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element-binding protein and co-regulatory molecule CREB-binding proteins (Richards, 
2001).   Channel phosphorylation most often occurs with either PKA and protein kinase 
C (Béguin, 1999).  PKA phosphorylation of L-type Ca2+ channels is a recognized method 
of regulation in many cell types (Kang et al, 2006).  After being phosphorylated, the 
kinetics of the channel changes or more channels become active in the plasma membrane 
(Béguin, 1999).  In β-cell lines KATP channels have been shown to be regulated by PKA 
phosphorylation (Béguin, 1999).  PKA has a wide variety of targets that have effects on 
cellular responses.  
Exchange Protein Activated by Cyclic AMP 
 Epac is a cAMP regulated guanine nucleotide exchange factor (Holz et al, 2004).  
The hypothesized structure suggests the regulatory domains auto-inhibit binding of Rap 
from binding due to steric hindrance (Ponsioen et al, 2004).  At low levels of cAMP Epac 
is folded, covering binding domains, which lead to its inactive state.  Once cAMP binds 
Epac unfolds, exposing the Rap binding site (Ponsioen et al, 2004).  Two different forms 
of Epac exist: Epac 1 and Epac 2, which are both present in the pancreas (Holz et al, 
2004; Kang et al, 2006).   (Note that in this research there will be no differentiation 
between the two forms of Epac.)  Cyclic AMP binding affinity for Epac is similar to the 
binding affinity to PKA (Holz et al, 2004).  Epac interacts with a variety of proteins.  
Epac stimulates Rap 1 and Rap 2, hormone gene expression, phoshilpase C-epsilon, 
integrin-mediated cell adhesion, cardiac gap junction formation, vascular endothelial cell 
barrier formation and cell signaling (Holz et al, 2004).  Evidence also suggests that Epac 
might affect ion channels and exocytosis in excitable cells (Kang et al, 2006).  
Interactions between Epac and a subunit of the KATP channel and secretory granule 
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associated proteins may lead to exocytosis in excitable cells (Kang et al, 2006).  Epac 1 
and Epac 2 may both serve as accessory subunits of the KATP channel possibly with the 
SUR1 subunit (Holz et al, 2006).  Both Epac 1 and Epac 2 immunoprecipitate with the 
KATP channel subunit SUR1, indicating an interaction (Kang et al, 2006; Holz et al, 
2004).  A β-cell model supports the idea that cAMP may be working through Epac in 
order to regulate KATP channels (Kang et al, 2006).   The use of Epac analogues led to 
KATP channel inhibition in β-cells (Kang et al, 2006).  Epac-mediated actions also 
influence Na2+, K+, Ca2+, and Cl- channel functions (Holz et al, 2004).    
 Through its various effects within cells Epac may influence Ca2+ concentrations 
(Holz et al, 2004).  Epac-mediated actions help mobilize Ca2+ from intracellular stores 
through either IP3 receptors or ryanodine receptors by opening the channels (Holz et al, 
2006).  Epac through Rap and ERK phosphorylation of channels increases sensitivity to 
Ca2+ or Ca-mobilizing second messengers (Holz et al, 2004).   
 
 
 
Figure Two: Cyclic AMP’s potential targets within α-cells. After formation of cAMP the 
specific targets and functions are not understood. 
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Thesis objective 
 Stimulation of melanocortin or β-adrenergic receptors leads to an increase of the 
second messenger cAMP in α-cells.  The function of this second messenger on glucagon 
secretion is still not understood.  Since glucagon secretion is a Ca2+ dependent process 
there might be a relationship linking cAMP and Ca2+ in α-cells.  The studies conducted 
for this thesis were aimed at determining this link and included assessment of PKA-
dependent and PKA-independent pathways and investigation of the various ion channels 
involved. 
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Methods and Materials 
 
Culturing α-cells 
 Two related clonal mouse alpha cell lines were used. αtc1-6 cells were provided 
by Professor Donald Steiner from the University of Chicago and αtc1-9 cells were 
obtained from the American Type Culture Collection.  Cells were cultured in DMEM 
glucose adjusted to 15 mM, 10% Heat Inactivated Fetal Bovine Serum, 1% 10X MEM, 
1% Penicillin/Streptomyocin, 1%, Sodium Pyruvate and 0.1% Normacin,  
Cultures were maintained in a humidified incubator at 36.7°C (5% CO2).  Cells were 
detached from cell culture flask by use of Trypsin EDTA.   
Plating α-cells 
 For imaging experiments, cells were plated in glass bottom culture dishes 35/12 
mm (Warner Instruments, Cat 64-0757) or in plastic dishes on micro cover glass (VWR 
Scientific Inc, Cat 48366 067).  Cover glass had been pretreated with either Poly-L 
Lysine or with Polyethylenimine (PEI).  Cells were imaged on day two and three after 
plating cells.   
Fura-2 AM Loading  
 Cells were loaded with the ratiometric dye Fura-2 AM (5 µM ) for 30 minutes at 
room temperature while protected from light. Fura data are expressed in ratios of 380/340 
image. Data were normalized to initial values to allow for comparison between the two 
imaging systems used.  All reported fura ratio values are at least 2-fold below saturation 
as assessed with saturating Ca2+ levels induced by ionomycin. 
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 External solutions contained varying amounts of potassium, sodium and glucose 
ranging from 2 mM K+ to 60 mM K+ and 0 mM glucose to 15 mM glucose.  External 
solutions contained 1 mM MgCl2, 10 mM HEPES (adjusted to pH 7.2) , 5 mM CaCl2,  
and 2 mM KCl with 140 NaCl or 60 KCl with 82 mM NaCl (60 mM K+ solution). D-
glucose was present at 2, 8, or 15 mM.  Zero Ca2+ solution contained 1 mM EGTA and 
no CaCl2.  
Bath Perfusion Experiments 
 Cells were visualized with a Zeiss AxioVert S100, with a 40x oil objective lense, 
images were captured using a Cooke SensiCam CCD Camera (PCO Imaging).  The 
microscope contained 10% transmittance neutral density filters.  Images were acquired 
and analyzed using Slidebook software, exposure times for 340 nm and 380 nm of light 
were 25 ms and images were binned 4x4.  Intermittent perfusion was performed during 
imaging using a gravity flow system.  Suction was set up on one side of the dish, while 
inflow was set up on the opposite side.  In flow ranged from 0.5 ml per minute to 1 ml 
per minute.  At specific time points valves to solutions were opened and drained for a set 
amount of time.  When small amounts of solutions were used the solution was pushed 
slowly through the tubing with a syringe.  At the end of each experiment solution was 
changed to a 60 mM K+ solution in order to check cell function. 
Puffing Experiments 
Cells were visualized with a Olympus 1X71, with a 40x air objective lens.  The 
microscope contained 25% transmittance filters.  Images were captured using a Hamatsu 
Orca camera. Images were acquired and analyzed using Slidebook software, exposure 
times for 340 nm and 380 nm of light were 50 ms and images were binned 8x8.  Drugs 
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were applied to clusters of cells using PicoSpritzer® II (Parker Hannifin Corporation) for 
5 seconds.  Following the experiment a visual check was made to make sure the pipette 
tip did not move or break during the experiment.  
Membrane Potential Experiments 
 The slow response molecular probe Bisoxonol reports large changes in membrane 
potential.  Bisoxonol is a lipophilic anion that increases fluorescence with depolarization, 
while hyperpolarization leads to a decrease in fluorescence.  αTC cells were loaded with 
30 nM Bisoxonol for 20 minutes prior to imaging to allow the Bisoxonol to equilibrate.  
Bisoxonol was present in all solutions during imaging at 30 nM concentration.   
 Cells were visualized with an Zeiss AxioVert S100, with a 40x oil objective lens, 
images were captured using a Cooke SensiCam CCD Camera (PCO Imaging).  The 
microscope contained 10% transmittance filters.  Images were acquired and analyzed 
using Slidebook, exposure times for 480 nm excitation light were 3 ms and images were 
binned 2×2.  Images were acquired at five-second intervals.  Constant perfusion was 
performed during imaging.  Suction was set up on one side of the dish, while inflow was 
set up on the opposite side.  Constant perfusion was performed because this is not a 
ratiometric dye and is therefore sensitive to focal change.  Bath solution changes were 
made with gravity flow system.  At specific times valves to solutions were opened and 15 
seconds later the original open valve was closed.   
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Ethanol Control 
 An ethanol control was performed in order to ensure that ethanol had no effect on 
α-cells.  0.5 % ethanol was added to bath solution and 60 mM K+ was applied to the cells 
using PicoSpritzer® II (Parker Hannifin Corporation) for 5 seconds.  Lower starting 
concentrations of Ca2+ were observed.  Stock solutions were made more concentrated in 
order to bypass any effects of ethanol. 
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Table One: Drugs used During Experiments 
Information pertaining to different drugs used during experimental procedures.  Brief 
descriptions of drug function, procedural concentrations, stock concentrations and solvent 
used for the stock solution.  For drugs dissolved in DMSO the dilution to the procedural 
concentration is included in order to ensure a low percent of DMSO in the final solution. 
Name Function Procedural 
Concentration 
Stock 
Concentration 
Stock 
Solvent 
Forskolin Activates Adenyalte 
Cyclase, raises levels 
of cAMP 
50 µM 
(1:200) 
10 mM DMSO 
IBMX Inhibits PDE, keeps 
cAMP high 
1 µM 
(1:500) 
500 mM DMSO 
RpCamps PKA inhibitor, NOT 
EPAC 
11 µM 22 mM Water 
Tolbutamide Potassium channel 
blocker 
100 µM Ranged from 
99.85-106 mM 
Water 
8 Br-cAMP Membrane permeable 
cAMP 
2.3 mM 233 mM Water 
PMA Activates protein 
kinase C 
100 nM 3.24 mM  
Nifedipine Blocks L-type calcium 
channels 
5 µM or 10µM 2.28 mM Ethanol 
Conotoxin N-type calcium 
channel blocker 
1µM  228 mM Water  
Diazoxide Opens voltage-gated 
potassium channel 
530 µM or  
106 µM 
265 mM Ethanol 
8-CPT-2’-O- Me 
cAMP 
EPAC activator 50 µM    
20 µM     
50 mM  Water 
6-Bnz cAMP PKA activator 20 µM 10 mM Water 
Caffeine Opens Ryanodine 
Receptors 
1 mM 10 mM Water 
Ryanodine [nM] Holds channel 
half open. 
[µM] Closes 
ryanodine receptor  
100 µM 10 mM Water 
Rp-MB-cAMPs, Na Competitivie inhibitor 
of PKA types I and II 
110 µM 5 mM Water 
Fura-2 AM Calcium indicator dye  5 µM 
(1:200) 
1 mM DMSO 
Ionomycin Raises intracellular 
calcium 
  DMSO 
H89 Inhibits PKA 48 µM 9.6 mM Water 
DDA  Blocks Clyclases 50 µM    8.5 mM  Water 
Bis-oxonol   Measures membrane 
potential 
30 nM                 
(1:1000)   
300 µM DMSO 
 20 
Table Two:  Abbreviated Nomenclature 
 Abbreviated nomenclature for various drugs used during experiments. 
Name Abbreviation 
7β-Acetoxy-8,13-epoxy-1α,6β,9α-trihydroxylabd-
14-en-11-one 
Forskolin 
3-Isobutyl-1-methylxanthine IBMX 
Rp-cAMPs RpCamps 
1-Butyl-3-(4-methylphenylsulfonyl)urea Tolbutamide 
8-Bromoadenosine-3′,5′-cyclic 
monophosphorothioate, Rp-isomer 
8 Br-cAMP 
Phorbol 12-myristate 13-acetate PMA 
4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-
pyridinedicarboxylic acid dimethyl ester 
Nifedipine 
ω-conotoxin Conotoxin 
7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-
dioxide 
Diazoxide 
8-(4-Chlorophenylthio)-2'-O-methyladenosine-
3',5'-cycli c monophosphate sodium salt 
8-CPT-2’-O-Me cAMP 
Biolog 
N6-Benzoyladenosine-3′,5′-cyclic monophosphate 
sodium salt 
6-Bnz cAMP 
Calbiotech 
1,3,7-Trimethylxanthine Caffeine 
Ryanodine Ryanodine 
Adenosine 3′,5′-cyclic Monophosphorothioate, 2′-
O-Monobutyryl-, Rp-Isomer, Sodium Salt 
Rp-MB- camps, Na  
Calbiotech 
Ryanodol 3-(1H-pyrrole-2-carboxylate) Fura-2 AM 
Invitrogen 
Ionomycin calcium salt Ionomycin 
H89 Dihydrochloride H89 
2,5 Dideoxyadenosine DDA  
(DiBAC4(3))  Bis-oxonol    
Molecular Probes, B438 
Polyethyleneimine PEI 
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Results 
Comparison of Pancreatic α-Cell Lines 
 Studies of alpha cell signaling can be simplified by monitoring activity in the 
absence of paracrine factors. This requires a pure cell population such as can be obtained 
with clonal cell lines. Currently there are two related mouse α-cell lines (αTC1-6 and 
αTC1-9) primarily used in research. Gene expression studies in the lab have indicated 
that these cells differ with respect to MC4R expression and adenylyl cyclase and PDE 
isoforms (Lumsden MS thesis, 2008; E. Joachim unpublished). My first experiments 
assessed whether differences also exist in the way these cells respond to stimulation.  
When both cell lines were stimulated with varying amounts of glucose, changes in 
intracellular calcium were recorded.   
 Figure 3 shows the effects of changing glucose concentrations on intracellular 
calcium concentrations in the two α-cell lines.  When αTC1-6 cells were changed from a 
2 mM glucose solution to an 8 mM glucose solution, intracellular calcium concentration 
decreased when these cells were perfused with a 15 mM solution, intracellular Ca2+ 
concentrations began to increase.  The response in αTC1-9 cells did not parallel the 
response in αTC1-6 cells.  No changes in calcium concentration were observed when 
cells were taken from 2 mM glucose to 8 mM glucose, and minimal increases were 
observed when αTC1-9 cells were incubated in 15 mM glucose.  Initially the cells were 
bathed in 2 mM K+, 2 mM glucose external solution for 30 minutes.  After 100 seconds 
of imaging the external solution was changed to 2 mM K+, 8 mM glucose external 
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solution.  At 250 seconds after the beginning of imaging, external solution was changed 
to 2 mM K+, 15 mM glucose external solution.  A final solution change occurred at 500 
seconds when the solution was changed to 60 mM K+, 2 mM glucose to depolarize the 
cells. Both cell lines were treated under the same conditions. 
 All subsequent experiments were carried out in αTC1-6 cells.  Glucose 
concentrations were varied as indicated, however 8 mM glucose, which reflects normal 
resting glucose in vivo was the standard condition. 
 High glucose concentrations close the KATP channel in β-cells, leading to an 
overall membrane depolarization.  α-Cells have the same KATP channel and L-type 
calcium channel, but possess an N-type calcium channel and sodium channel.  In order to 
assess KATP channel influence on Ca2+ influx, KATP channels were held closed with 
tolbutamide and open with diazoxide.  
KATP channels effects on pancreatic α-cells 
 Potassium channels were pharmacologically blocked in α-cells to determine role 
of potassium channels in calcium influx in α-cells.  A comparison was made between the 
effects of tolbutamide (a KATP channel inhibitor) in 2 mM glucose and 8 mM glucose in 
αTC1-6 cells (Figure 4).  Tolbutamide had little effect on intracellular calcium 
concentrations in 2 mM glucose.  In 8 mM glucose, calcium concentrations increased 
after the addition of tolbutamide as seen in Figure 4 C and D.  Addition of Diazoxide, a 
compound that opens KATP channels, caused an increase in Ca2+ concentrations in α-cells 
in 8 mM glucose (Figure 5).  This increase is not what would be expected, which could 
possibly be caused by the activation of N-type calcium channels. 
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 There were several possibilities of calcium channels involvement in Ca2+ influx.  
The next experiments were aimed at determining which calcium channels were opened 
when α-cells underwent strong, rapid depolarization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Comparison of αTC1-6 and αTC1-9 cell lines calcium influx in response to 
varying glucose concentrations.  Panel A shows αTC1-6 average trace with error bars, 
panel B shows αTC1-9 average trace with error bars. 
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Figure 4: Comparison of effects of Tolbutamide in 2 mM glucose and 8 mM glucose. 
 Cells in panels A and B are in 2 mM K+, 2 mM glucose external solution.  At 317 
seconds external solution containing Tolbutamide [100 µM] was perfused into the bath.  
At 530 seconds external solution was changed to one containing 60 mM K+, 2 mM 
glucose.  In panels C and D cells were in 2 mM K+, 8 mM glucose external solution.  At 
300 seconds external solution was changed to 2 mM K+, 8 mM glucose external solution 
containing Tolbutamide [100 µM]. At 530 seconds external solution was changed to one 
containing 60 mM K+, 8 mM glucose.  
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Figure 5: Diazoxide effect of αTC1-6 cells in 8 mM glucose.  Panel A shows all traces 
of all cells within the dish.  Panel B shows the average trace with error bars of all the 
cells. 
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Calcium channel activation during stimulation of α-cells with 60 mM K+ in 8 mM 
glucose 
 Alpha cells were stimulated with five-second puffs of 60 mM K+.  Figure 6 shows 
the calcium concentrations changes due to membrane depolarization.  The first pulse of 
potassium resulted in the highest calcium influx.  Subsequent pulses decreased in 
intensity.  After four stimulatory puffs of high potassium solution, calcium concentrations 
started to increase without stimulation, possibly due to calcium-induced calcium release.  
In order to determine which types of calcium channels were involved in the calcium 
influx different channel blockers were applied to the cells prior to stimulation with 60 
mM K+. 
 Treatment with the L-type Ca2+ channel blocker, nifedipine [10 µM], resulted in a 
block of calcium response from the high potassium stimulation.  Several experiments 
were conducted on different days in order to ensure that intracellular calcium 
concentrations were prevented from increasing in the presence of nifedipine when 
stimulated with high concentrations of external potassium. 
 Treatment with the N-type Ca2+ channel blocker, ω-conotoxin [1 µM], did not 
result in a complete block of Ca2+ influx but did affect the calcium response.  Calcium 
influx was limited by the third stimulatory puff of high external potassium (Fig 6 c). 
After several experiments of observing the effects of ω-conotoxin different responses 
were observed.  The average trace shows that stimulation with high external potassium 
causes an increase in Ca2+ concentrations.  The various effects of ω-contoxin are shown 
in figure seven.  In some instances no increase in Ca2+ concentrations were observed, 
while in other instances large increases in the concentration of Ca2+ were observed. 
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Figure 6: Effects of Membrane Depolarization on Ca2+ Levels 
 Cells were loaded with Fura-2 AM in 2 mM K+, 8 mM glucose external solution.  
Five-second application of 60 mM K+ are represented by arrows in the above panels.  
Puffs were made every minute for six minutes.  Panel A shows the average trace of 60 
mM K+ puffs without the presence of any inhibitory drugs.  Panel B shows the average 
trace of 60 mM K+ in the presence nifedipine [10 µM].  Panel C shows the average trace 
of 60 mM K+ in the presence of ω-conotoxin [1 µM]. 
 
 In euglycemic conditions L-type calcium channels open in response to membrane 
depolarization, while N-type calcium channels are near the threshold of inactivation. In 
type-1 diabetes the quantity of β-cells decreases, which creates overall higher blood 
glucose levels.  In higher levels of plasma glucose α-cell function could be altered.  In 
order to determine how α-cell function differs in higher glucose, the same experiment 
was done in the presence of 15 mM glucose. 
Calcium channel involvement during stimulation of α-cells with 60 mM K+ in 15 
mM glucose 
 Alpha cells were stimulated with five-second puffs of 60 mM K+.  Figure 8 shows 
the calcium concentration changes due to depolarization in high glucose.  The first pulse 
of potassium resulted in the highest calcium influx.  Subsequent pulses decreased in 
intensity.   
 Treatment with the L-type Ca2+ channel blocker, nifedipine, resulted in a partial 
block of response from the high potassium stimulation.  Treatment with the N-type Ca2+ 
channel blocker, ω-conotoxin, also resulted in a partial block of Ca2+ influx.  When 
stimulated in the presence of both toxins, residual calcium influx occurred, suggesting the 
presence of R-type current. 
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Figure Seven: Average and individual traces of 60 mM K+ application in the presence of 
ω-conotoxin. 
 Panel A shows the average trace with error bars in response to 60 mM K+ 
application in 8 mM glucose.  Panels B through D show different types of responses to 60 
mM K+ application in the presence of ω-conotoxin [1 µM] in 8 mM glucose.   
 
Puffing and Perfusion of Forskolin 
 Epinephrine and αMSH are known to activate Gαs, leading to stimulation of 
adenylyl cyclase creating cAMP.  Since only the pathway of cAMP was of interest 
pharmacological agents could be used to create intracellular cAMP.  8 Br-cAMP [2.3 
mM] was applied to α-cells in order to observe α-cell response to cAMP (data not 
shown).  Minimal Ca2+ influx was observed from application of 8 Br-cAMP. Since 8 Br-
cAMP is not very membrane permeable, the pharmacological andenylyl cyclase activator, 
forskolin was applied to increase intracellular concentrations of cAMP. 
 Alpha cells stimulated with a five-second puff of the adenylyl cyclase activator 
forskolin [50 µM] respond with increasing Ca2+ concentrations (Figure 9).  Similarly 
when α-cells were stimulated with forskolin for prolonged periods of time, they also have 
an increase in Ca2+ concentrations.  A five-second puff of forskolin is likely more similar 
to a physiological stimulus because adenylate cyclase is not continuously stimulated. 
Forskolin Response After Removing Calcium 
 Perfusion and brief application of forskolin both lead to an increase in 
intracellular Ca2+.  The Ca2+ influx is a slow response that looks similar to calcium-
induced calcium release.  In order to determine if this influx is calcium-induced calcium 
release, calcium was removed from the extracellular solutions, which would indicate any 
Ca2+ increase was due to internal store release. 
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Figure Eight:  Potassium application in 15 mM Glucose. 
 Cells were loaded with Fura-2 AM in 2 mM K+, 15 mM glucose external solution.  
5-second puffs of 60 mM K+ are represented by arrows in the above panels.  Puffs were 
made every minute for six minutes.  Panel A shows the average trace of 60 mM K+ puffs 
without the presence of any inhibitory drugs. Panel B shows the average trace of 60 mM 
K+ in the presence of ω-conotoxin [1 µM].  Panel C shows the average trace of 60 mM 
K+ in the presence nifedipine [10 µM].  Panel D shows the average trace of 60 mM K+ in 
the presence of ω-Conotoxin and Nifedipine. 
 
 Figure 10 shows a strong depolarization from 60 mM K+, from a perfusion 
experiment in the presence of calcium.  Membrane depolarization causes an increase in 
calcium concentration.  When αTC1-6 cells are stimulated with forskolin [50 µM] in the 
presence of calcium and then calcium is removed after the response begins, the calcium 
concentration continues to increase suggesting store release. Note that a subsequent 60 
mM K+ stimulation with calcium in the external solution now gives only a weak 
response.   
 Before Ca2+ is removed from solution Ca2+ enters the cell through voltage-gated 
Ca2+ channels, followed by store release.  Stimulation of α-cells with 60 mM K+ in 8 mM 
glucose led to Ca2+ influx through L-type Ca2+ channels.  Ca2+ influx after stimulation 
with forskolin led to influx through Ca2+ channels.  The next set of experiments will 
determine which Ca2+ channels are involved in this influx. 
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Figure 9: Perfusion and Picosprtizing Forskolin on αTC1-6 cells 
 Panel A shows a five-second stimulation of α-cells with forskolin [50 µM]. Panel 
B shows a bath perfusion experiment using forskolin [50 µM]. 
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In response to forskolin calcium concentrations increased even in the presence of ω-
conotoxin.  The increase was similar to the increase following forskolin alone.  The 
calcium concentration increase was completely inhibited by the presence of nifedipine 
[20 µM].  After stimulation with forskolin, there was no apparent change in calcium 
concentrations, indicating L-type Ca2+ channel involvement.  The specific cAMP 
pathway that led to the opening of the L-type channel is not specified by this experiment.  
In order to determine the specific method of activation further experiments were 
performed. 
Calcium Channel Participation after Forskolin Stimulation 
 During a five-second stimulation with forskolin [50 µM], αTC1-6 cells had a 
gradual increase in calcium concentration.  In order to determine what calcium channels 
are involved in the increase in calcium concentration, calcium channel blockers were 
applied prior to stimulation with forskolin.  As shown in Figure 11 (panels B and C), 
calcium current blockers nifedipine [10 µM] or ω-conotoxin [1 µM] were applied.  In 
response to forskolin calcium concentrations increased even in the presence of ω-
conotoxin.  The increase was similar to the increase following forskolin alone.  The 
calcium concentration increase was completely inhibited by the presence of nifedipine 
[20 µM].  After stimulation with forskolin, there was no apparent change in calcium 
concentrations, indicating L-type Ca2+ channel involvement.  The specific cAMP 
pathway that led to the opening of the L-type channel is not specified by this experiment.  
In order to determine the specific method of activation further experiments were 
performed.   
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Figure 10: Forskolin stimulation and transfer to zero calcium. 
 Cells were loaded with Fura-2 AM in 2 mM K+, 8 mM glucose external solution.  
Panel A shows perfusion of 60 K+ at 300 seconds.  Panel B shows perfusion of forskolin 
[50 µM] at 200 seconds followed by perfusion of zero calcium and EGTA [0.5 mM] 
external solution with forskolin at 320 seconds. Final solution change to 60 mM K+ was 
made at 605 seconds. 
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Figure 11:  Forskolin application and block with channel blockers. 
 Panel A shows a 5-second application with forskolin [50 µM] in 8 mM glucose.  
Panel B shows forskolin stimulation after treatment with ω-conotoxin [1 µM].  Panel C 
shows forskolin stimulation after treatment with nifedipine [10 µM].  Arrows indicate 
moment of forskolin application. 
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Cyclic AMP Dependent Pathways in α-cells 
 As previously described, cAMP has several potential pathways that affect cellular 
responses (Gromada et al, 2007).  In order to establish the cAMP pathways activated, α-
cells were incubated with a membrane permeant cAMP analog that specifically activates 
PKA or a membrane permeant cAMP analog that specifically activates EPAC.  Figure 12 
shows a 5-second stimulation with forskolin [50 µM], to increase cAMP levels (which 
would activate both PKA and EPAC).  Panel B shows the stimulation with an EPAC 
analog (8-CPT-2’-O-Me) [20 µM].  A five-second stimulation causes a slow increase in 
calcium concentration.  Similarly stimulation with the PKA analog (6-Bnz- cAMP) [20 
µM] causes a slow increase in Ca2+ concentrations.  Both PKA and EPAC lead to Ca2+ 
influx within α-cells.  Further experiments were performed to determine which Ca2+ 
channels led to the Ca2+ influx for both cAMP pathways. 
Potential Pathways of EPAC within α-cells 
 Epac was shown to stimulate Ca2+ increase in α-cells.  In order to determine if 
EPAC has an effect on Ca2+ channels or store release, several channel blockers were 
used.  In the presence of the N-type calcium channel blocker, ω-conotoxin [1 µM], 
calcium concentrations increased following application of forskolin [50 µM].  In the 
presence of the L-type calcium channel blocker, nifedipine [10 µM], calcium 
concentrations did not change following stimulation with forskolin [50 µM]. In order to 
determine if Ca2+ increase from EPAC is dependent on the presence of extracellular Ca2+, 
or if store release could be directly activated, Ca2+ was removed from the extracellular 
solution.  Prior to the five-second application of 8-CPT-2’-O-Me cAMP extracellular  
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Figure 12: Potential pathways of cAMP  
 Panel A shows stimulation forskolin [50 µM] at the arrow for point of application.  
Panel B shows stimulation with 8-CPT-2’-O-Me cAMP [20 µM], the arrow shows time 
of five-second application.  Panel C shows stimulation with 6-Bnz cAMP [20 µM], the 
arrows show the time of five-second application. 
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solution was switched to a solution without calcium and with EGTA [0.5 mM] present to 
chelate Ca2+ ions.  After stimulation of EPAC, no calcium response was observed.  
Potential Pathways of PKA within α-cells 
 It is known that PKA phosphorylates channels as a method of regulation (Kang et 
al, 2006).  Since PKA was shown to stimulate calcium increase within α-cells, to 
determine PKA’s effects on calcium channels, channel blockers were applied.  In the 
presence of the N-type Ca2+ channel blocker, ω-conotoxin [1 µM], calcium 
concentrations increased.  Compared to PKA activation in absence of ω-conotoxin, 
calcium concentration influx is slightly decreased.  The L-type calcium channel blocker, 
nifedipine [10 µM], completely blocked calcium concentration increase.  In order to 
determine if calcium increase from PKA is dependent on the presence of extracellular 
calcium, calcium was removed from the extracellular solution.  Prior to the five-second 
application of 6-Bnz-cAMP, extracellular solution was switched to a solution without 
calcium and EGTA [0.5 mM] present in order to chelate calcium ions.  After stimulation 
of PKA, no calcium response was observed. 
 Both EPAC and PKA stimulation appeared to cause calcium-induced calcium 
release.  In order to determine the channels releasing Ca2+ from the endoplasmic 
reticulum, ryanodine was used to block the ryanodine receptor. 
Ryanodine Effects of cAMP Dependant Pathways 
 In β-cells calcium from the endoplasmic reticulum is mobilized from ryanodine-
sensitive receptors and IP3 receptors (Seino, 2005).  Ryanodine at micromolar 
concentrations blocks the ryanodine-sensitive receptor.  Ryanodine was applied to α-cells 
in order to determine if calcium released from the endoplasmic reticulum through 
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Figure 13: Potential pathways of EPAC 
 Panel A shows the average trace after stimulation from EPAC analog, 8-CPT-2’-
O-Me cAMP [20 µM].  Panel B shows the average trace after stimulation from EPAC 
analog in the presence of ω-conotoxin [1 µM]. Panel C shows the average trace after 
stimulation from EPAC analog in the presence of nifedipine.  Panel D shows stimulation 
from EPAC analog in the absence of external calcium and presence of EGTA [0.5 mM].  
Arrows indicate the time of application of EPAC analog. 
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ryanodine-sensitive receptor.  Stimulation of PKA caused an increase in calcium 
concentration in α-cells.  When ryanodine [100 µM] was applied to α-cells, calcium 
concentration increase was not inhibited.  When EPAC was applied to α-cells, an 
increase in calcium concentration was also observed.  After application of ryanodine, 
cells still have an increase in Ca2+ concentrations.  Pre-incubation in ryanodine [100 µM] 
did not cause a block of calcium increase. 
 In order to ensure that the ryanodine was able to block the ryanodine receptor, it 
was tested on skeletal muscle cells.  Cultured muscle cells contracted in response to 
electrical stimulation.  Ryanodine blocked muscle contraction.  This indicated that the 
ryanodine was functional.  (Data not shown). 
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Figure 14: Potential pathways of Protein Kinase A 
 Panel A shows stimulation from PKA analog [20 µM].  Panel B shows 
stimulation from PKA analog in the presence of ω-conotoxin [1 µM]. Panel C shows 
stimulation from PKA analog in the presence of nifedipine [10 µM].  Panel D shows 
stimulation from PKA analog in the absence of external calcium and presence of EGTA 
[0.5 mM].  Arrows indicate moment of five-second application of PKA analog. 
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Figure 15:  Ryanodine Effects on cAMP Dependant Pathways 
 Panel A shows stimulation from PKA analog (6-Bnz cAMP) [20 µM].  Panel B 
shows stimulation from PKA analog in the presence of ryanodine [100 µM]. Panel C 
shows stimulation from EPAC analog (8-CPT-2’-O-Me cAMP) [20 µM].  Panel D shows 
stimulation from EPAC analog in the presence of ryanodine [100 µM].  Arrows indicate 
moment of five-second application of specified analog. 
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Relative Changes in Membrane Potential 
 Observing changes in membrane potential would lead to further understanding of 
Ca2+ influx in α-cells.  EPAC or PKA stimulation within the cell could cause Ca2+ 
influxes to occur through membrane potential changes.  In order to determine if the Ca2+ 
influx was due to a change in membrane potential bisoxonol was applied to α-cells.   
 Changes in glucose concentrations impacted Ca2+ influx in α-cells.  The closure 
of the KATP channel led to opening of voltage-gated Ca2+ channels.  In order to observe 
membrane potential changes in different glucose concentrations bisoxonol was applied to 
α-cells. 
 αTC1-6 cells were equilibrated with bisoxonol and imaged.  Cells were treated 
with forskolin and for strong membrane depolarization.  No change in fluorescence 
occurred after the addition of forskolin.  The slope of the average trace does not change 
noticeably.  When cells were exposed to different concentrations of glucose, a change in 
fluorescence can be observed when glucose was changed from 8 mM to 15 mM.  The 
cells appear to depolarize when changing from 8 mM glucose to 15 mM glucose. 
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Figure 16: Membrane potential changes measured by Bisoxonol 
 External solution containing bisoxonol [30 nM] and forskolin [50 µM] was added 
at 100 seconds.  External solution was changed to 60 mM K+ external solution at 475 
seconds.  Panel A shows individual traces.  Panel B shows the average of the individual 
traces. 
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Figure 17: Effects of glucose concentration on membrane potential 
 Bisoxonol measurements of membrane potential with changes in glucose 
concentrations.  Panel A shows individual traces.  Panel B shows the average of the 
individual traces. 
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Discussion 
 Glucose stimulation experiments in αTC1-9 and αTC1-6 cells suggest that a 
difference exists between the cell lines.  In αTC1-9 cells calcium concentrations do not 
vary between 2 mM glucose and 8 mM glucose.  A slight increase in calcium occurs 
when glucose is raised to 15 mM.  In αTC1-6 cells, calcium concentrations decrease 
when the external solution is changed from 2 mM glucose to 8 mM glucose, suggesting 
mild depolarization may cause inactivation of N-type calcium or Na+ channels.  Stronger 
depolarization occurs when the glucose concentration is switched from 8 mM to 15 mM 
glucose.  KATP channels are closing with the increase in glucose concentrations causing a 
depolarization.  Physiologically this creates a conundrum about α-cell stimulation.  α-
Cells should not depolarize in high glucose concentrations, since they release glucagon to 
raise blood sugar.  This suggests that paracrine or endocrine factors are stimulating or 
inhibiting α-cells.  This experiment also shows that 8 mM glucose is a good 
concentration to use to study α-cells because α-cells Ca2+ is relatively stable, and more 
importantly, this concentration of glucose would be a resting blood glucose level. 
 Tolbutamide was used to pharmacologically block KATP channels.  In β-cells 
tolbutamide causes depolarization and in turn an increase in intracellular calcium.  α-
Cells in 2 mM glucose show a lack of response to tolbutamide and a small response in 8 
mM glucose (Figure 4).   Differences in responses of α-cells and β-cells might be due to 
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differences in KATP channel sensitivity.  Differences might also exist between glucose 
sensitivity between cell types.   
 When cells are treated diazoxide, KATP channels are held open, which should 
cause the cells to hyperpolarize.  A Ca2+ influx is witnessed after the application of 
diazoxide in 8 mM glucose (Figure 5).  It is likely that an initial hyperpolarization by 
diazoxide relieves inactivation of Na+ channels and N-type channels.  This could lead to 
opening of these channels and a subsequent depolarization and Ca2+ influx. The 
observation that subsequent high K+ does not lead to further Ca2+ suggests the cells were 
strongly depolarized by that point. 
 Strong depolarizations can be produced in α-cells through high concentrations of 
K+.  Using a picospritzer to apply short puffs of solution allows for a closer to 
physiological stimulation.  Cells were stimulated with 60 mM K+ at one-minute intervals 
(Figure 6).  Under 8 mM glucose, depolarization produced a calcium influx and gradually 
led to calcium-induced calcium release.  When calcium channel blockers were added to 
the solution, the cellular responses varied.  Nifedipine blocks L-type calcium channels.  
When nifedipine was applied to α-cells prior to puffs of 60 mM K+, the calcium increase 
was inhibited, indicating that L-type calcium channels are necessary for Ca2+ influx in α-
cells in 8 mM glucose.  Application of ω-conotoxin, used to block N-type Ca2+ channels, 
did not have complete block of Ca2+ influx.  Responses in the presence of ω-conotoxin 
varied: one response to stimulation, cells would respond to all stimulations and 
sometimes cells lack responses all together (Figure 7).  This may reflect an intermediate 
membrane potential in 8 mM glucose such that the degree of inactivation of N-type 
channels was highly variable between cells. 
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 In 15 mM glucose α-cells respond differently to stimulation of high K+ (Figure 
8).  The addition of ω-conotoxin, there is a definite decrease in the Ca2+ concentration 
response due to stimulation, indicating that N-type calcium channels play a role in Ca2+ 
influx.  Nifedipine has a similar response in 15 mM glucose, presenting only a partial 
block of the 60 mM K+ response.  With the addition of both ω-conotoxin and nifedipine 
together a small Ca2+ influx still exists.  Since both N- and L-type Ca2+ channels are 
blocked, another channel is involved in the Ca2+ influx.  R-type Ca2+ channels participate 
in this depolarization.  Traditionally, R-type Ca2+ channels are resistant to the calcium 
channel blockers nifedipine and ω-conotoxin.  The role of R-type calcium channels in 
hyperglycemic becomes apparent because Ca2+ influx is still observed in the presence of 
channel blockers. These channels participate very minimally, if at all, in 8 mM glucose, 
which can be demonstrated by the ability of nifedipine to completely block Ca2+ 
responses. The mechanism by which high glucose makes R-type channels available is not 
known. 
Cyclic AMP Effects in α-cells  
 Forskolin is stimulates adenylate cyclase and leads to an increase in cAMP.  
When forskolin is applied to α-cells through a five-second puff, it causes an increase in 
Ca2+ concentrations (Figure 9).   
 In αTC1-9 cells, a rise in intracellular Ca2+ was not consistently obtained. To 
obtain a Ca2+ influx from cAMP during perfusion, a combination of forskolin and IBMX 
must be used (data not shown).  IBMX inhibits phosphodiesterase (PDE), preventing the 
degradation of cAMP, and this causes extremely high levels of cAMP within the cells.  
αTC1-6 cells do not require PDE inhibition to provide an increase in Ca2+ concentrations.  
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 When αTC1-6 cells are stimulated by perfusion with forskolin in the presence of 
Ca2+ and then Ca2+ is removed, an increase in intracellular Ca2+ is still observed, which 
suggests that cAMP is causing Ca2+ induced Ca2+ release (CICR) (Figure 10).  CIRC 
requires and initial influx of Ca2+ to occur. 
 Forskolin causes an increase in Ca2+ concentration.  In order to determine the 
channels playing a role in the Ca2+ increase, Ca2+ channel blockers were applied (Figure 
11).  Addition of ω-conotoxin did not cause a block in Ca2+ increase, indicating that N-
type Ca2+ channels are not being affected by cAMP.  Addition of nifedipine shows a 
block of Ca2+ influx, providing evidence that L-type Ca2+ channels are impacted by 
cAMP.    
  In order to further characterize the pathway of cAMP two targets of cAMP can 
be analyzed.  One possibility to determine PKA functions would be to block PKA. 
Preliminary attempts were made to block the actions of PKA by use of Rp-cAMPs with 
stimulation from α-MSH.  Rp-cAMPs did not have high membrane permeability and did 
not seem to have an effect on α-cell function (unpublished data from Liang Liang).  Use 
of Rp-MB-cAMPs, is a more membrane permeable compound.  Some increase in Ca2+ 
still occurs after application with Rp-MB-cAMPs Na+, which indicates another pathway 
other than PKA exists in Ca2+ influx or that inhibition of PKA was incomplete. Both 
versions of Rp-cAMPs are ~50-fold less membrane permeant than the cAMP analogs that 
stimulated PKA or EPAC. 
 To determine the role of PKA in α-cells, the ser/thr kinase inhibitor H89 was 
used.  H89, a known inhibitor of PKA, was applied to αTC1-9 cells and a variation of 
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responses occurred (data not shown).  However, it was concluded that H89 was having 
nonspecific effects on depolarization induced Ca2+ influx. 
 Specific activators for PKA and EPAC exist and can be used to determine how 
cAMP functions in α-cells.  By comparing the Ca2+ response of forskolin to individual 
responses of stimulated EPAC and PKA, allowed for further characterization of α-cell 
pathways (Figure 12).  8-CPT-2’-O-Me cAMP (EPAC analog) stimulates Ca2+ increases 
in αTC1-6 cells, and 6-Bnz cAMP (PKA analog) also stimulates Ca2+ increase in αTC1-6 
cells.  After determining that cAMP uses both EPAC and PKA in Ca2+ influx, further 
investigations can determine the specific targets of both in α-cells.   
 To determine EPACs targets within α-cells combinations with ω-conotoxin and 
nifedipine allowed for a more in depth analysis (Figure 13).  When 8-CPT-2’-O-Me 
cAMP was applied in the presence of ω-conotoxin, Ca2+ influx was not inhibited.  Thus, 
N-type Ca2+ channels are not stimulated by EPAC in α-cells.  Application of nifedipine 
prior to stimulation with 8-CPT-2’-O-Me cAMP blocks Ca2+ influx, suggesting that       
L-type channels interact with EPAC.  Stimulation with 8-CPT-2’-O-Me cAMP in zero 
Ca2+ and in the presence the Ca2+ cheltor EGTA, resulted in a reduced Ca2+ influx, which 
indicates that Ca2+ influx is required in order to have Ca2+ release from stores. 
 Similar experiments were done to determine the pathway of PKA in α-cells by 
using ω-conotoxin and nifedipine (Figure 14). A five-second pulse of 6-Bnz cAMP 
applied in the presence of ω-conotoxin, resulted in only a slight decrease in Ca2+ influx.  
This suggests that N-type channels are potentially a target for PKA in α-cells.  Nifedipine 
completely blocked Ca2+ influx from stimulation of 6-Bnz cAMP.  This block indicates 
L-type channels interact with PKA to induce an increase in Ca2+ in α-cells.  Additionally, 
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stimulation with 6-Bnz cAMP in 0 Ca2+ in the presence of EGTA prevented Ca2+ influx. 
Showing that Ca2+ influx is necessary in order to have Ca2+ store release.   
Potential Role of Ryanodine 
 Ryanodine receptors are activated in the presence of caffeine. α-cells were treated 
with caffeine to determine if ryanodine receptors play a role in Ca2+ release from 
intracellular stores.  When caffeine alone was applied to α-cells, there was no immediate 
increase in Ca2+ concentration (data not shown). When cells were stimulated with 60 mM 
K+ in the presence of caffeine, a slight increase in Ca2+ was noticed compared to control 
conditions.  Ryanodine receptors would also have been open before stimulation in the 
presence of caffeine and would have ideally shown an increase in Ca2+ concentrations.  
The increased response may be due to some opening of ryanodine receptors.     
 In order to determine the pathway in which EPAC and PKA are causing store 
release, ryanodine was used.  At micromolar concentrations ryanodine will close the 
ryanodine-sensitive receptor, preventing Ca2+ release from stores.  Ryanodine was 
applied to cells before imaging started (Figure 15).  When cells were incubated in 
ryanodine, there was no difference in Ca2+ influx (data not shown).  When α-cells were 
stimulated with 8-CPT-2’-O-Me cAMP in the presence of ryanodine; there was no block 
of Ca2+ concentration increase.  Similar results occurred with the application of 6-Bnz 
cAMP in the presence of ryanodine, there was no apparent change in Ca2+ concentration 
increase.  In order to ensure that store release is not coming from the ryanodine-sensitive 
receptor, the quality of the ryanodine had to be determined.  Muscle cells depend on 
calcium store release in order to contract.  Electrical stimulation of muscle cells results in 
muscle contraction.  Ryanodine applied at the same concentration used in the α-cell 
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experiments, was applied to muscle cells.  Complete block of muscle contraction upon 
stimulation confirmed that the ryanodine was functional.  Thus, EPAC and PKA do not 
cause Ca2+ increases by release through ryanodine-sensitive channels in α-cells.  The 
most likely pathway of this Ca2+ release is therefore through IP3 receptor in both EPAC 
and PKA pathways. 
 Lastly bisoxonol was used to evaluate changes in membrane potential.  Addition 
of forskolin to α-cells caused a small depolarization.  This indicates that cAMP is has an 
effect on membrane potential.  Interestingly addition of α-MSH causes the membrane to 
hyperpolarize (data not shown).  Since α-MSH causes an increase in cAMP, one would 
expect a similar reaction.     
 Changing glucose concentrations also had an effect on membrane potential 
(Figure 17).  By looking at the graph it is indicated that as glucose concentrations 
increase the membrane becomes slightly more depolarized.  More KATP channels close 
with increased glucose concentrations.  As more ATP is produced in the cell more 
channels will be shut down leading to more membrane depolarization.  Bisoxonol only 
gives general information on membrane potential and does not allow determination of 
specific membrane potentials.  In order to precisely determine membrane potentials patch 
clamp recordings would have to be taken.   
Protein kinase C/PMA 
 PMA [100 nM] was used to test the role of protein kinase C (PKC) in α-cells after 
stimulation by 60 mM K+ (data not shown).  When bath solution was changed to 60 mM 
K+ in the presence of PMA and was again changed to a 2 mM K+ solution calcium-
induced calcium release took place.  The activation of PKC increased the cells likelihood 
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of having calcium-induced calcium release.  In order to fully understand the mechanisms 
in which PKC is causing this increase in Ca2+, further research would need to done to 
determine the specific targets of PKC in α-cells.   
Future Directions 
  These experiments answered many questions, while opening the door to many 
other questions.  Glucose concentrations were shown to affect Ca2+ influx in α-cells.  In 
order to know what Ca2+ currents are affected from the changes in glucose, patch clamp 
recordings could be performed to determine the exact channels involved.  Patch clamp 
recording would also give a more accurate picture of membrane potential changes with 
changing glucose concentrations.   
 The ryanodine receptor does appear to be involved in Ca2+ store in α-cells, which 
is somewhat surprising.  No good IP3 blockers exist, so determining its function would be 
more complicated.  Knocking out transcripts leading to the formation of the IP3 receptor 
would allow for a study of its function in α-cells.  Small interfering RNA could be used 
to knock the production of the IP3 receptor.  By knocking out this transcript in a α-cell 
line, one could determine if the IP3 receptor leads to intracellular Ca2+ store release. 
 Determining the way α-cells functions ultimately leads to a bigger picture 
understanding of glucose homeostasis.  In type-1 diabetes, β-cell function is untimely 
lost, leading to higher plasma glucose levels.  Observing that α-cells are stimulated in 
high glucose leads to the conclusion that α-cells are causing additional increases in 
plasma glucose levels.  Pharmacological agents can be produced to specifically target  
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α-cell function to help manage glucose increases within the body.  Knowing pathways 
within α-cells that lead to increases in Ca2+ can help determine ways to regulate these 
cells. 
 56 
 
 
 
Bibliography 
2000.  Nomenclature for Voltage gated Calcium Channels. Neuron 25: 533-535. 
Ashcoroft F. 2000.  Ion Channel and Disease. Academic Press.  
Béguin P, Nagashima, K, Nishimura M, Gonoi T, Seino S.  1999. PKA-mediated  
 phosphorylation of the human KATP channel: separate roles of Kir6.2 and SUR1 
 subunit phosphorylation.  The EMBO Journal: 18: 4722-4732.  
Bos J.  2006.  EPAC proteins: multi-purpose cAMP targets. Trends in Biochemical  
 Sciences: 31(12): 680-686. 
Cabrera O, Berman D, Kenyon N, Ricordi C, Berggren P, and Caicedo A.  2006. The  
 unique cytoarchitecture of human pancreatic islets has implications for islet cell  
 function.  PNAS 103 (7): 2334-2339. 
Catterall WA, Perez-Reyes E, Snutch TP, Striessing J.  2005.  International Union of  
 Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of  
 Voltage-Gated Calcium Channels. Pharmacological Reviews: 57(4): 411–425. 
Chen Z, Li Z, Peng G, Chen X, Yin W, Kotlikoff MI, Yuan Z, Ji G.  2009.  Extracellular  
 ATP-induced nuclear Ca2+ transient is mediated by inositol 1,4,5-trisphosphate  
 receptors in mouse pancreatic β-cells. Biochemical and Biophysical Research  
 Communications: 382(2): 381-384. 
Cone, R.  2006.  Studies on Physiological Functions of the Melanocortin System.  
Endocrine Reviews: 27(7): 736. 
 57 
Ganong W F.  Review of Medical Physiology. 2005. 
Gromada J, Franklin I, Wollheim C. 2007. α-cells of endocrine pancreas: 35 years of  
 research but the enigma remains.  Endocrine Reviews 28 (1): 84-116.  
Hochgeschwender U, Costa J L, Reed P, Bui S, Brennan M B. 2003.  Altered Glucose  
 Homeostatsis in Proopiomelanocortin-Null Mouse mutants Lacking Central and 
 Peripheral Melanocortin. Endocrinology 144 (12): 5194-5202.  
Holz G, Kang G, Harbeck M, Roe MW, Chepruny OG. 2006. Cell physiology of cAMP  
 sensor Epac. Journal of Physiology: 577, 5-15 
Holz G.  2004.  Epac: A New cAMP-Binding protein in support of glucagon-like peptide- 
 1 receptor-mediated signal transduction in pancreatic β-cell.  Diabetes: 53: 5-13. 
Kang G, Chepurny O, Holz G.  2004.  cAMP-regulated guanine nucleotide exchange 
 factor II (Epac2) mediates Ca-induced Ca release in INS-1 pancreatic β-Cells.  The 
 Journal of Physiology: 536(2): 375-385. 
Kang G, Chepurny OG, Malester B, Rindler MJ, Rehmann H, Bos JL, Schweded F, 
 Coetzee WA, Holz GG.  2006.  cAMP sensor Epac as a determinant of ATP- 
 sensitive potassium channel activity in human pancreatic beta cells and rat INS-1  
 cells.  Journal of Physiology: 573: 595-609. 
Koster J, Permutt M, Nichols C.  2005.  Diabetes and insulin secretion: The ATP- 
 Sensitive K channel (KATP) Connection. Diabetes 54: 3065-3072. 
MacDonald P E, Zhang De Marinis Y, Ramracheya R.  2007.  A KATP channel-dependant  
 pathway within α cells regulates glucagon release from both rodent and human  
 islets of langerhans. PLoS: 5(6): e143. 
Millington G W.  2007. The role of proopiomelanocortin (POMC) neurones in feeding 
 58 
 behavior. Nutrition & Metabolism: 4(18). 
Ponsioen B, Zhaon J, Riedle J, Zwartkruis F, Van der Krogt G, Zaccolo M, Moolenaar 
 W, Bos JL, Jalink K.  2004. Detecting cAMP-induced Epac activation by  
 fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO 
 Reports: 5(12) 1176-1180. 
Pritchard LE, Turnbull AV, White A.  2002.  Pro-opiomelanocortin processing in the  
 hypothalamus: impact on melanocortin signaling and obesity. Journal of  
 Endocrinology: 172(3): 411-421. 
Quesada I, Todorova M G, Alonso-Magdalena P, Beltrá M, Carneiro E M, Martin F, 
 Nadal A, Soria B.  2006.  Glucose induces opposite intracellular Ca2+ concentration 
 oscillatory patterns in identified alpha- and beta-cells within intact human islets of  
 Langerhans. Diabetes: 55: 2463-2469. 
Quesada I, Tuduri E, Ripoll C, Nadal A. 2008. Physiology of the pancreatic a-cell and  
 glucagon secretion: role in glucose homeostasis and diabetes. Journal of 
 Endocrinology 199, 5-19.  
Rana, B.  2003. New insights into G-protein-coupled receptor signaling from the  
 melanocortin receptor system. Molecular Pharmacology 64(1): 1-4. 
Ravier MA, Rutter GA.  2005.  Glucose or insulin, but not zinc ions, inhibit glucagon 
 secretion from mouse pancreatic alpha-cells. Diabetes: 54(6) 1789-1797.  
Richards J S. 2001. New signaling pathways for hormones and cyclic adenosine 3’,5’- 
 Monophosphate action in endocrine cells.  Molecular Endocrinology: 15 (2): 209- 
 218. 
Rorsman P, Salehi SA, Abdulkader F, Braun M, MacDonald PE.  2008.  KATP- 
 59 
 channels and glucose-regulated glucagon secretion. Trends in  
 Endocrinology and Metabolism: 19(8). 
 
Rorsman P.  2003.  Insulin granule dynamics in pancreatic beta cells. Diabetologia: 
 46(8): 1029-1045.  
Seino S, Shibasak T.  2005. PKA-Dependent and PKA-Independent Pathways for cAMP- 
 Regulated Exocytosis Physiological Reviews: 85(4): 1303-1342. 
Walsh DA, Van Patten SM.  1994. Multiple Pathways signal transduction by the cAMP- 
 dependant protein kinase. The FASEB Journal: 8(15) 1227-1236.  
Yaswen L, Diehl N, Brennan M B, Hochgeschwender U.  1999. Obesity in the mouse 
 model of pro-opiomelanocortin deficiency responds to peripheral melanocortin.   
 Nature Medicine: 5(9): 1066-1070. 
 
 
 
 
